Skip to main navigation Skip to search Skip to main content

exPDite-2: A Phase 3 Study to Assess the Efficacy and Safety of Midbrain Dopaminergic Neuronal Cell Therapy(Bemdaneprocel) for Participants With Parkinson's Disease

  • Thyagarajan, Dominic (Primary Chief Investigator (PCI))
  • Evans, Andrew Howard (Chief Investigator (CI))
  • Evans, Andrew Howard (Chief Investigator (CI))
  • Sue, Carolyn M. (Chief Investigator (CI))
  • Lehn, Alexander (Chief Investigator (CI))
  • Vijiaratnam, Nirosen (Chief Investigator (CI))
  • Sue, Carolyn M. (Chief Investigator (CI))
  • Lehn, Alexander (Chief Investigator (CI))
  • Heshmat, Saman (Chief Investigator (CI))
  • Yau, Wai Yan (Chief Investigator (CI))

Project: Research

Project Details

StatusActive
Effective start/end date1/08/25 → 31/07/27

Keywords

  • Clinical Trial
  • BRT-DA01-301

Clinical Trial Phase

  • Phase III (a & b)